<div id="readability-page-1"><div>TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick &amp; Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (“KSF”) are investigating the proposed merger of Titan Pharmaceuticals, Inc. (the “Company”) (NasdaqCM: TTNP) and KE Sdn. Bhd. Under the terms of the proposed transaction, shareholders of Titan are expected to own approximately 13.3% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to the Company’s shareholders. If you would like to discuss your legal rights regarding the proposed transaction, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-ttnp/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. Kahn Swick &amp; Foti, LLC 1100 Poydras St., Suite 960 New Orleans, LA 70163 CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNTA4MDU1MzcwODRyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNTA4MDU1MzcwODRyMQ"/> Lewis S. Kahn lewis.kahn@ksfcounsel.com 855-768-1857 View source version on businesswire.com: https://www.businesswire.com/news/home/20250805537084/en/</div></div>

Titan制藥

Kahn Swick & Foti, LLC，由前路易斯安那州檢察長 Charles C. Foti, Jr.領導，正在調查 Titan Pharmaceuticals, Inc.（TTNP）與 KE Sdn. Bhd.之間的擬議合併。Titan 的股東預計將擁有合併實體約 13.3% 的股份。該公司旨在評估合併過程對 Titan 股東的公平性和充分性。感興趣的各方可以聯繫 KSF 以獲取有關與該交易相關的法律權利的更多信息

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

路易斯安那州前總檢察長髮布 Titan 製藥投資者警報：Kahn Swick & Foti, LLC 正在調查 Titan 製藥公司（TTNP）的合併事宜